# Tigecycline

NDC: 71288-019
Generic name: Tigecycline
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210513

FDA application: ANDA214020

## Active ingredients

- TIGECYCLINE: 50 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cbefeb0-7d63-4c49-9906-384acc53dd15